Overbey Katherine, Romano Francesco, Ding Xinyi, Bennett Cade F, Stettler Isabella, Garg Itika, Ploumi Ioanna, Vingopoulos Filippos, Yuan Melissa, Razavi Peyman, Finn Matthew, Laíns Inês, Patel Nimesh A, Kim Leo, Wu David, Eliott Dean, Husain Deeba, Vavvas Demetrios, Miller Joan W, Miller John B
Harvard Retinal Imaging Lab, Massachusetts Eye and Ear, Boston, MA, USA.
Retina Service, Department of Ophthalmology, Massachusetts Eye and Ear, Boston, MA, USA.
Br J Ophthalmol. 2025 Aug 20;109(9):1020-1027. doi: 10.1136/bjo-2024-326416.
To assess choriocapillaris flow deficit percentage (CCFD%) across stages of dry age-related macular degeneration (AMD) using swept-source optical coherence tomography angiography (SS-OCTA).
This cross-sectional, observational study included 270 eyes (182 patients), classified as early (70 eyes), intermediate (121 eyes) and geographic atrophy (GA, 79 eyes).Participants underwent a complete examination including macular 6×6 mm SS-OCTA scans (PLEX Elite 9000). Scans were reviewed and analysed for subretinal drusenoid deposits (SDDs), retinal pigment epithelium (RPE) atrophy size, incomplete RPE and outer retinal atrophy (iRORA) and drusen volume (3 mm). CCFD% was calculated after compensation and binarisation using Phansalkar's method (r=4-15 pixels) in various early treatment for diabetic retinopathy study sectors. Linear mixed-effects models adjusted for age evaluated associations with AMD stages and other imaging biomarkers.
CCFD% progressively increased with advancing dry AMD stages. Intermediate AMD eyes showed higher CCFD% than early AMD ones across all regions (p<0.001). GA eyes exhibited significantly higher CCFD% compared with early (p<0.001) and intermediate AMD eyes (p<0.001).SDDs were significantly associated with higher CCFD% in early (p<0.01) and intermediate AMD (p<0.05) for almost all regions examined, but not in GA (p>0.05). iRORA presence in iAMD and larger RPE atrophy in GA correlated with increased CCFD% (p<0.001).
This study provides a comprehensive reference database for CCFD% across the stages of dry AMD using SS-OCTA. CCFD% increased with AMD severity, iRORA, SDDs, particularly in early and intermediate stages, and RPE atrophy size. Our findings support CCFD% as a valuable biomarker for clinical and research applications, warranting longitudinal studies to validate its prognostic value.
使用扫频源光学相干断层扫描血管造影(SS-OCTA)评估干性年龄相关性黄斑变性(AMD)各阶段的脉络膜毛细血管血流缺损百分比(CCFD%)。
这项横断面观察性研究纳入了270只眼(182例患者),分为早期(70只眼)、中期(121只眼)和地图样萎缩(GA,79只眼)。参与者接受了包括黄斑6×6 mm SS-OCTA扫描(PLEX Elite 9000)在内的全面检查。对扫描结果进行回顾和分析,以检查视网膜下玻璃膜疣样沉积物(SDD)、视网膜色素上皮(RPE)萎缩大小、不完全RPE和外层视网膜萎缩(iRORA)以及玻璃疣体积(3 mm)。在糖尿病视网膜病变早期治疗研究的各个区域,使用Phansalkar方法(r = 4 - 15像素)进行补偿和二值化后计算CCFD%。采用年龄校正的线性混合效应模型评估与AMD阶段和其他影像生物标志物的关联。
CCFD%随着干性AMD阶段的进展而逐渐增加。在所有区域,中期AMD眼的CCFD%均高于早期AMD眼(p < 0.001)。与早期(p < 0.001)和中期AMD眼(p < 0.001)相比,GA眼的CCFD%显著更高。在几乎所有检查区域,早期(p < 0.01)和中期AMD(p < 0.05)的SDD与更高的CCFD%显著相关,但在GA中无相关性(p > 0.05)。iAMD中iRORA的存在以及GA中更大的RPE萎缩与CCFD%增加相关(p < 0.00¹)。
本研究使用SS-OCTA为干性AMD各阶段的CCFD%提供了一个全面的参考数据库。CCFD%随着AMD严重程度、iRORA、SDD(特别是在早期和中期)以及RPE萎缩大小的增加而增加。我们的研究结果支持CCFD%作为临床和研究应用中有价值的生物标志物,需要进行纵向研究以验证其预后价值。